• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Structure-pharmacokinetic relationships among the barbiturates in the rat.

作者信息

Toon S, Rowland M

出版信息

J Pharmacol Exp Ther. 1983 Jun;225(3):752-63.

PMID:6864531
Abstract

The pharmacokinetics of a congeneric series of barbituric acids were determined after i.v. administration of individual barbiturates or multicomponent barbiturate mixtures to chronically cannulated male rats. The concentration of barbiturate in plasma and urine was determined using reversed-phase high-performance liquid chromatography. A biexponential equation adequately fitted the plasma-concentration time data. The volume of distribution remained relatively constant within the series. Binding to plasma proteins varied enormously, increasing with lipophilicity. Accordingly, the volume of distribution based on unbound drug also increased with lipophilicity, reflecting a corresponding greater tissue affinity. Total clearance formed a relatively complex nonlinear relationship with lipophilicity. Although the affinity of the barbiturates for erythrocytes increased with lipophilicity, the relationship between total blood clearance and lipophilicity offered no simplification. Renal clearance, the minor route of elimination for the majority of the homologs, decreased with increasing lipophilicity, due to increased tubular reabsorption, whereas nonrenal (hepatic) clearance produced a nonlinear relationship with lipophilicity similar in form to that of total clearance. The nonlinearity of the hepatic clearance within the series was explained by a hepatic blood flow limitation, for the highest homologs, and by the stereochemistry of position 5 on the barbituric acid ring, for the lowest homologs.

摘要

相似文献

1
Structure-pharmacokinetic relationships among the barbiturates in the rat.
J Pharmacol Exp Ther. 1983 Jun;225(3):752-63.
2
Pharmacokinetics of some homologous series of barbiturates in the intact rat and in the isolated perfused rat liver.
J Pharmacol Exp Ther. 1977 Oct;203(1):184-92.
3
Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.静脉推注和持续输注后完整猪体内吲哚菁绿的血浆清除:分光光度法和高压液相色谱法用于浓度分析的比较
Hepatology. 1993 Dec;18(6):1504-15.
4
Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.定量构效关系:I. 构建一个基于生理学的全身模型以表征大鼠体内一系列同系巴比妥类药物的药代动力学变化
J Pharmacokinet Biopharm. 1997 Jun;25(3):277-312. doi: 10.1023/a:1025771608474.
5
Structure-pharmacokinetic relationships among the N1,N3-alkylxanthines in rats.
J Pharm Pharmacol. 1991 Apr;43(4):262-9. doi: 10.1111/j.2042-7158.1991.tb06680.x.
6
Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure.
J Pharmacol Exp Ther. 1986 Sep;238(3):978-84.
7
Relationship between lipophilicity and tubular reabsorption for a series of 5-alkyl-5-ethylbarbituric acids in the isolated perfused rat kidney preparation.
J Pharm Sci. 1988 Apr;77(4):359-64. doi: 10.1002/jps.2600770416.
8
Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.绿草定(3,5,6-三氯-2-吡啶氧基乙酸)在比格犬和恒河猴体内的药代动力学:关于犬相对于大鼠、猴和人类排泄这种有机酸能力降低的研究视角
Toxicol Appl Pharmacol. 1997 Jun;144(2):268-78. doi: 10.1006/taap.1997.8136.
9
Plasma protein binding and metabolic clearance of phenytoin in the rat.
J Pharmacol Exp Ther. 1977 Dec;203(3):500-6.
10
The clinical pharmacokinetics of vinorelbine (Navelbine).长春瑞滨(诺维本)的临床药代动力学。
Semin Oncol. 1994 Oct;21(5 Suppl 10):21-7.

引用本文的文献

1
Pharmacokinetic and Metabolic Characteristics of Herb-Derived Khellactone Derivatives, A Class of Anti-HIV and Anti-Hypertensive: A Review.一类具有抗HIV和抗高血压作用的草本来源凯林内酯衍生物的药代动力学和代谢特征:综述
Molecules. 2016 Mar 8;21(3):314. doi: 10.3390/molecules21030314.
2
New methodology for the synthesis of thiobarbiturates mediated by manganese(III) acetate.新型锰(III)醋酸盐介导的硫代巴比妥酸合成方法。
Molecules. 2012 Apr 10;17(4):4313-25. doi: 10.3390/molecules17044313.
3
Maximizing the chances of detecting pathogenic leptospires in mammals: the evaluation of field samples and a multi-sample-per-mammal, multi-test approach.
最大化在哺乳动物中检测致病性钩端螺旋体的机会:野外样本评估及每只哺乳动物多个样本、多种检测方法
Ann Trop Med Parasitol. 2011 Mar;105(2):145-62. doi: 10.1179/136485911X12899838683205.
4
Drug structure-transport relationships.药物结构-转运关系。
J Pharmacokinet Pharmacodyn. 2010 Dec;37(6):541-73. doi: 10.1007/s10928-010-9174-0. Epub 2010 Nov 24.
5
Modeling kinetics of subcellular disposition of chemicals.化学物质亚细胞分布动力学建模。
Chem Rev. 2009 May;109(5):1793-899. doi: 10.1021/cr030440j.
6
Prediction of in vivo tissue distribution from in vitro data. 3. Correlation between in vitro and in vivo tissue distribution of a homologous series of nine 5-n-alkyl-5-ethyl barbituric acids.根据体外数据预测体内组织分布。3. 9种5 - n -烷基 - 5 -乙基巴比妥酸同系物的体外与体内组织分布之间的相关性。
Pharm Res. 2003 Jun;20(6):864-72. doi: 10.1023/a:1023912318133.
7
Quantitative structure-pharmacokinetics relationships: II. A mechanistically based model to evaluate the relationship between tissue distribution parameters and compound lipophilicity.定量构效关系:II. 一种基于机制的模型,用于评估组织分布参数与化合物亲脂性之间的关系。
J Pharmacokinet Biopharm. 1998 Oct;26(5):521-45. doi: 10.1023/a:1023221116200.
8
Physiologically based pharmacokinetic modeling of a homologous series of barbiturates in the rat: a sensitivity analysis.大鼠中一系列同源巴比妥类药物的基于生理的药代动力学建模:敏感性分析
J Pharmacokinet Biopharm. 1997 Aug;25(4):413-47. doi: 10.1023/a:1025740909016.
9
Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.定量构效关系:I. 构建一个基于生理学的全身模型以表征大鼠体内一系列同系巴比妥类药物的药代动力学变化
J Pharmacokinet Biopharm. 1997 Jun;25(3):277-312. doi: 10.1023/a:1025771608474.
10
Discrepancies in pharmacokinetic parameter estimation between bolus and infusion studies in the perfused rat hindlimb.灌注大鼠后肢的推注和输注研究之间药代动力学参数估计的差异。
J Pharmacokinet Biopharm. 1995 Oct;23(5):441-62. doi: 10.1007/BF02353468.